SCHEMBL14196177

SCHEMBL14196177

CCN(CC)CCCOC1C=c2c(Cc3ccc(NCC4C=CC(Cl)=CC4)nc3)c[nH]c2=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14196171 0.81 CYP3A4 (0.35) —
SCHEMBL14197869 0.80 CSF1R (0.43) —
SCHEMBL13977459 0.79 — —
SCHEMBL14197870 0.70 CSF1R (0.49) —
SCHEMBL14197362 0.69 CYP2C19 (0.33) —
SCHEMBL14198421 0.69 CSF1R (0.56) —
SCHEMBL14194091 0.69 CYP3A4 (0.60) —
SCHEMBL14197360 0.69 CSF1R (0.53) —
SCHEMBL14194082 0.68 CYP3A4 (0.48) —
SCHEMBL14198428 0.68 CYP3A4 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008064265-A2 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR PLEXXIKON, INC. (US) 2008-05-29 — — WO disclosed
Send feedback